Wall Street brokerages started covering SoftBank Group-backed Tempus AI (TEM.O), opens new tab on a bullish note on Tuesday, betting that the company's AI-powered library of clinical and molecular data could lead to more powerful diagnostic and test kits.
The Chicago, Illinois-based company sells genomic diagnostics tests across oncology and other areas, including neuropsychiatry, radiology and cardiology to clinicians and hospital systems.
Read more here
https://www.reuters.com/technology/artificial-intelligence/wall-street-analysts-bullish-genetic-testing-firm-tempus-ai-2024-07-09/
You are viewing a single comment's thread from:
There are so many fields being open up for data. It is amazing.